SG
MRNA icon

StoneX Group’s Moderna MRNA Stock Holding History

StoneX Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,412
Closed -$217K – 426
2023
Q1 		$217K Sell
1,412
-11
-0.8% -$1.81K 0.13% 268
2022
Q4 		$255K Buy
+1,423
New +$233K 0.04% 345
2022
Q1 		– Sell
-1,164
Closed -$296K – 604
2021
Q4 		$296K Buy
1,164
+82
+8% +$24K 0.03% 410
2021
Q3 		$416K Sell
1,082
-206
-16% -$76K 0.06% 293
2021
Q2 		$303K Buy
+1,288
New +$230K 0.04% 356

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

StoneX Group's MRNA Position: Q2 2023 in Review

StoneX Group sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,412 shares — an estimated $217K sold.

StoneX Group first reported a position in MRNA in Q2 2021 and held it in 5 quarters. The position peaked at $416K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • StoneX Group reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • StoneX Group sold 1,412 Moderna shares in Q2 2023, an estimated $217K.
  • StoneX Group first reported a position in Moderna in Q2 2021 and held it in 5 quarters.
  • StoneX Group's Moderna position peaked at $416K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on StoneX Group's 13F filing for Q2 2023, filed 14 Aug 2023.